{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T07:09:56Z","timestamp":1765177796662},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.trim.2017.06.001","type":"journal-article","created":{"date-parts":[[2017,6,19]],"date-time":"2017-06-19T21:46:23Z","timestamp":1497908783000},"page":"42-48","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Immunogenicity of Class I HLA but not preformed low MFI donor specific antibodies correlates with outcomes after first renal transplantation"],"prefix":"10.1016","volume":"43-44","author":[{"given":"A.","family":"Lobashevsky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Goggins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Rosner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Taber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.trim.2017.06.001_bb0005","first-page":"78","article-title":"Donor HLA mismatch determines the risk of HLA locus-specific sensitisation and access to repeat kidney transplantation following primary allograft failure","volume":"26","author":"Gjorgjimajkoska","year":"2013","journal-title":"Transpl. Int."},{"key":"10.1016\/j.trim.2017.06.001_bb0010","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/ki.2014.106","article-title":"Impact of donor mismatches at individual HLA-A, \u2212B, \u2212C, \u2212DR, and -DQ loci on the development of HLA-specific antibodies in patients listed for repeat renal transplantation","volume":"86","author":"Kosmoliaptsis","year":"2014","journal-title":"Kidney Int."},{"key":"10.1016\/j.trim.2017.06.001_bb0015","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/TP.0b013e31827a19cc","article-title":"Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation","volume":"95","author":"Tait","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2017.06.001_bb0025","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1111\/ajt.13452","article-title":"Assessing HLA antibody strength: have we thought about everything?","volume":"15","author":"Visentin","year":"2015","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2017.06.001_bb0030","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/TP.0b013e3181856ffa","article-title":"Antibody monitoring: a solid approach to predicting clinical outcome","volume":"86","author":"Zachary","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2017.06.001_bb0035","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/01.tp.0000250492.55775.83","article-title":"Analysis of HLA class I specific antibodies in patients with failed allografts","volume":"83","author":"Mao","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2017.06.001_bb0040","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1097\/00007890-199706150-00014","article-title":"Postoperative production of anti-donor antibody and chronic rejection in renal transplantation","volume":"63","author":"Abe","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2017.06.001_bb0045","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/MOT.0b013e3283626149","article-title":"Posttransplant monitoring of de novo human leukocyte antigen donor-specific antibodies in kidney transplantation","volume":"18","author":"Wiebe","year":"2013","journal-title":"Curr Opin Organ Tran"},{"key":"10.1016\/j.trim.2017.06.001_bb0050","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1681\/ASN.2009101065","article-title":"Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation","volume":"21","author":"Lefaucheur","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.trim.2017.06.001_bb0055","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1586\/1744666X.4.3.391","article-title":"Trends in HLA antibody screening and identification and their role in transplantation","volume":"4","author":"Murphey","year":"2008","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"10.1016\/j.trim.2017.06.001_bb0060","doi-asserted-by":"crossref","unstructured":"Bachelet T, Visentin J, Guidicelli G, Merville P, Couzi L, Taupin JL. Anti-HLA donor-specific antibodies are not created equally. Don't forget the flow... Transpl Int 2016; 29: 508\u2013510.","DOI":"10.1111\/tri.12745"},{"key":"10.1016\/j.trim.2017.06.001_bb0065","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.humimm.2011.02.002","article-title":"Donor human leukocyte antigen specific antibodies predict development and define prognosis in transplant glomerulopathy","volume":"72","author":"Eng","year":"2011","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.trim.2017.06.001_bb0070","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1600-6143.2012.04291.x","article-title":"Five-year outcomes in living donor kidney transplants with a positive crossmatch","volume":"13","author":"Bentall","year":"2013","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2017.06.001_bb0075","first-page":"158","article-title":"Impact of Donor HLA mismatch grade on recipient HLA locus-specific sensitisation in patients returning to the kidney transplant waiting list following a failed primary kidney allograft","volume":"13","author":"Gjorgjimajkoska","year":"2013","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2017.06.001_bb0080","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1111\/ajt.13347","article-title":"Part II: rates and determinants of progression for de novo Donor-specific antibody mediated kidney allograft injury","volume":"15","author":"Wiebe","year":"2015","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2017.06.001_bb0085","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/ajt.12968","article-title":"HLA-DR and -DQ Eplet mismatches and transplant Glomerulopathy: a nested case-control study","volume":"15","author":"Sapir-Pichhadze","year":"2015","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2017.06.001_bb0090","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/ndt\/16.5.897","article-title":"HLA-specific alloantibodies and renal graft outcome","volume":"16","author":"Sumitran-Holgersson","year":"2001","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.trim.2017.06.001_bb0095","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1681\/ASN.2014040326","article-title":"Non-complement-binding de novo Donor-specific Anti-HLA antibodies and kidney allograft survival","volume":"27","author":"Guidicelli","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.trim.2017.06.001_bb0100","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/ajt.12287","article-title":"Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA","volume":"13","author":"Reed","year":"2013","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2017.06.001_bb0105","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/TP.0000000000000315","article-title":"Deciphering complement interference in anti-human leukocyte antigen antibody detection with flow beads assays","volume":"98","author":"Visentin","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2017.06.001_bb0110","first-page":"216","article-title":"Deciphering IgM interference in IgG anti-HLA antibody detection with flow beads assays","volume":"78","author":"Visentin","year":"2016","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.trim.2017.06.001_bb0115","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/978-1-61779-842-9_17","article-title":"HLA antibody detection and characterization by solid phase immunoassays: methods and pitfalls","volume":"882","author":"Zachary","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.trim.2017.06.001_bb0120","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.trre.2013.07.001","article-title":"Interpretation of HLA single antigen bead assays","volume":"27","author":"Ellis","year":"2013","journal-title":"Transplant Rev (Orlando )"},{"key":"10.1016\/j.trim.2017.06.001_bb0125","doi-asserted-by":"crossref","first-page":"153","DOI":"10.5500\/wjt.v4.i3.153","article-title":"Methodological aspects of anti-human leukocyte antigen antibody analysis in solid organ transplantation","volume":"4","author":"Lobashevsky","year":"2014","journal-title":"World J. Transplant."},{"key":"10.1016\/j.trim.2017.06.001_bb0130","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.bbmt.2015.11.006","article-title":"Use of single-antigen flow beads assays to assess Anti-HLA Donor-specific antibody strength","volume":"22","author":"Loiseau","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.trim.2017.06.001_bb0135","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.humimm.2012.04.016","article-title":"Cutoff values and data handling for solid-phase testing for antibodies to HLA: effects on listing unacceptable antigens for thoracic organ transplantation","volume":"73","author":"Liu","year":"2012","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.trim.2017.06.001_bb0140","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.humimm.2009.09.358","article-title":"Improved Luminex-based human leukocyte antigen-specific antibody screening using dithiothreitol-treated sera","volume":"71","author":"Kosmoliaptsis","year":"2010","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.trim.2017.06.001_bb0145","first-page":"7","article-title":"A novel algorithm to predict HLA alloantigen immunogenicity based on the number and physiochemical properties of polymorphic amino acids","volume":"97","author":"Kosmoliaptsis","year":"2010","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.trim.2017.06.001_bb0150","first-page":"303","article-title":"Analysis of HLA alloantigen immunogenicity based on the physiochemical properties of polymorphic amino acids enables prediction of the magnitude of humoral immune responses","volume":"9","author":"Kosmoliaptsis","year":"2009","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2017.06.001_bb0155","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/TP.0000000000000355","article-title":"Differences in immunogenicity of HLA antigens and the impact of cross-reactivity on the humoral response","volume":"99","author":"Lucas","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2017.06.001_bb0160","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3389\/fimmu.2011.00059","article-title":"Humoral alloimmunity in transplantation: relevance of HLA epitope antigenicity and immunogenicity","volume":"2","author":"Duquesnoy","year":"2011","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trim.2017.06.001_bb0165","first-page":"420","article-title":"Immunogenicity of HLA class I Alloantigens defined at the molecular level correlates with outcome after renal transplantation","volume":"10","author":"Kosmoliaptsis","year":"2010","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2017.06.001_bb0170","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1097\/TP.0b013e31817441d6","article-title":"Predicting the immunogenicity of human leukocyte antigen class I alloantigens using structural epitope analysis determined by HLAMatchmaker","volume":"85","author":"Kosmoliaptsis","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2017.06.001_bb0175","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/MOT.0000000000000108","article-title":"Structural and electrostatic analysis of HLA B-cell epitopes: inference on immunogenicity and prediction of humoral alloresponses","volume":"19","author":"Mallon","year":"2014","journal-title":"Curr Opin Organ Tran"},{"key":"10.1016\/j.trim.2017.06.001_bb0180","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1097\/TP.0b013e3182007b74","article-title":"Human monoclonal antibody reactivity with human leukocyte antigen class I epitopes defined by pairs of mismatched eplets and self-eplets","volume":"90","author":"Marrari","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2017.06.001_bb0185","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.transproceed.2008.03.023","article-title":"Is there a differential strength of specific HLA mismatches in kidney transplants?","volume":"40","author":"Sasaki","year":"2008","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.trim.2017.06.001_bb0190","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.humimm.2009.09.074","article-title":"Predictive values of class I and class II antibodies detected by Luminex solid phase single antigen assay","volume":"70","author":"Lobashevsky","year":"2009","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.trim.2017.06.001_bb0195","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1097\/00007890-199706270-00007","article-title":"Determination of HLA-A, B residue maismatch acceptability for kidneys transplanted into highly sensitized patients: a report of a collaboratove study conducted during the 12th international histocompatibility workshop 1","volume":"63","author":"Duquesnoy","year":"1997","journal-title":"Clin. Transpl."},{"key":"10.1016\/j.trim.2017.06.001_bb0200","unstructured":"HLAMatchmaker, http:\/\/www.epitopes.net."},{"key":"10.1016\/j.trim.2017.06.001_bb0205","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0041-1345(00)02108-4","article-title":"HLAMATCHMAKER: a molecular based donor selection algorithm for highly alloimmunized patients","volume":"33","author":"Duquesnoy","year":"2001","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.trim.2017.06.001_bb0210","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0198-8859(02)00371-3","article-title":"The number of amino acid residues mismatches correlates with flow cytometry crossmatching results in high PRA renal patients","volume":"63","author":"Lobashevsky","year":"2002","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.trim.2017.06.001_bb0215","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.trim.2009.03.002","article-title":"Effect of desensitization in solid organ transplant recipients depends on some cytokines genes polymorphism","volume":"21","author":"Lobashevsky","year":"2009","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.trim.2017.06.001_bb0220","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0198-8859(02)00382-8","article-title":"HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. I. Description of the algorithm","volume":"63","author":"Duquesnoy","year":"2002","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.trim.2017.06.001_bb0225","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0198-8859(02)00381-6","article-title":"HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. II. Verification of the algorithm and determination of the relative immunogenicity of amino acid triplet-defined epitopes","volume":"63","author":"Duquesnoy","year":"2002","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.trim.2017.06.001_bb0230","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1097\/TP.0b013e31819f6328","article-title":"Structural limitations to the mimetic HLA epitope hypothesis","volume":"87","author":"Kosmoliaptsis","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2017.06.001_bb0235","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.1600-6143.2010.03013.x","article-title":"Proinflammatory events and HLA antibodies","volume":"10","author":"Zachary","year":"2010","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2017.06.001_bb0240","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1097\/00007890-200204270-00014","article-title":"Kidney graft failure and presensitization against HLA class I and class II antigens","volume":"73","author":"Susal","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2017.06.001_bb0245","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/ajt.13192","article-title":"HLA epitopes as viewed by antibodies: what is it all about?","volume":"15","author":"Tambur","year":"2015","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2017.06.001_bb0250","first-page":"161","article-title":"Unexpected frequencies of HLA antibody specificities in the sera of pre-transplant kidney patients","author":"Idica","year":"2006","journal-title":"Clin. Transpl."},{"key":"10.1016\/j.trim.2017.06.001_bb0255","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1097\/01.TP.0000120385.03278.28","article-title":"The number of amino acid triplet differences between patient and donor is predictive for the antibody reactivity against mismatched human leukocyte antigens","volume":"77","author":"Dankers","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2017.06.001_bb0260","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1097\/TP.0b013e3181b4a9ff","article-title":"Predicting HLA class I alloantigen immunogenicity from the number and physiochemical properties of amino acid polymorphisms","volume":"88","author":"Kosmoliaptsis","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2017.06.001_bb0265","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.humimm.2010.06.003","article-title":"HLA class I amino acid sequence-based matching after interlocus subtraction and long-term outcome after deceased donor kidney transplantation","volume":"71","author":"Kosmoliaptsis","year":"2010","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.trim.2017.06.001_bb0270","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1111\/ajt.12478","article-title":"Class II HLA epitope matching-a strategy to minimize de novo Donor-specific antibody development and improve outcomes","volume":"13","author":"Wiebe","year":"2013","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2017.06.001_bb0275","first-page":"158","article-title":"Epitope matching outperforms traditional antigen matching as a predictor of de novo Donor specific antibody development after renal transplantation","volume":"13","author":"Wiebe","year":"2013","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2017.06.001_bb0280","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.humimm.2009.04.011","article-title":"Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant","volume":"70","author":"Aubert","year":"2009","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.trim.2017.06.001_bb0285","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0041-1345(00)02096-0","article-title":"Low levels of HLA-specific antibody: relevance, detection, and treatment","volume":"33","author":"Zachary","year":"2001","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.trim.2017.06.001_bb0290","first-page":"461","article-title":"HLA DR subtypes induce IL-6 and TNF-alpha production in the primary mixed lymphocyte reaction","volume":"27","author":"Toungouz","year":"1995","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.trim.2017.06.001_bb0295","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00007890-199907270-00002","article-title":"The humoral immune response against an HLA class I allodeterminant correlates with the HLA-DR phenotype of the responder","volume":"68","author":"Fuller","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2017.06.001_bb0300","first-page":"57","article-title":"Delineation of the roles of paracrine and autocrine interleukin-6 (IL-6) in myeloma cell lines in survival versus cell cycle. A possible model for the cooperation of myeloma cell growth factors","volume":"16","author":"Jourdan","year":"2005","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.trim.2017.06.001_bb0305","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.4049\/jimmunol.1101230","article-title":"Characterization of a transitional preplasmablast population in the process of human B cell to plasma cell differentiation","volume":"187","author":"Jourdan","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.trim.2017.06.001_bb0310","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1038\/leu.2014.61","article-title":"IL-6 supports the generation of human long-lived plasma cells in combination with either APRIL or stromal cell-soluble factors","volume":"28","author":"Jourdan","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.trim.2017.06.001_bb0315","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/ajt.12202","article-title":"The house that Jack built: expanding the concept of plasma cell niches","volume":"13","author":"Valujskikh","year":"2013","journal-title":"Am. J. Transplant."}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327417300278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327417300278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T19:57:08Z","timestamp":1535745428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327417300278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":62,"alternative-id":["S0966327417300278"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2017.06.001","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity of Class I HLA but not preformed low MFI donor specific antibodies correlates with outcomes after first renal transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2017.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}